DAN A23 Pill - yellow oval
Pill with imprint DAN A23 is Yellow, Oval and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Schein.
Ranitidine is used in the treatment of GERD; Erosive Esophagitis; Gastric Ulcer Maintenance Treatment; Cutaneous Mastocytosis; Duodenal Ulcer and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DAN A23
Ranitidine Hydrochloride
- Imprint
- DAN A23
- Strength
- 300 mg
- Color
- Yellow
- Shape
- Oval
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Schein
- National Drug Code (NDC)
- 00364-2634 (Discontinued)
More about ranitidine
- Check interactions
- Compare alternatives
- Reviews (163)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
Patient resources
Other brands
Professional resources
- Ranitidine prescribing information
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.